Drug details

Lyvispah (baclofen oral granules)

type of Anticholinergic, Antispasmodic Agents

Lyvispah (baclofen) is a gamma-aminobutyric acid (GABA-ergic) agonist indicated for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity. Lyvispah may also be of some value in patient with spinal cord injuries and other spinal cord diseases. 

This drug may have the following side effects:

• confusion,
• itching,
• hives, 
• difficulty breathing, 
• swelling of your face, lips, tongue, or throat, 
• seizures, 
• drowsiness, and
• hallucinations, 
• high fever, 
• increased muscle stiffness, 
• numbness and tingling in your hands and feet,
• sleepiness 

The following drugs are related to Lyvispah, either as a replacement or used together:

• Lemtrada (alemtuzumab injection for intravenous infusion)
• Ampyra (dalfampridine extended-release tablets)
• Aubagio (teriflunomide tablets)
• Avonex (interferon beta-1a)
• Imuran (azathioprine)
• Betaseron (interferon beta-1b)
• Copaxone (glatiramer acetate)
• Tecfidera (dimethyl fumarate delayed release capsules)
• Gilenya (fingolimod capsules)
• Rebif (interferon beta-1a)
• Kesimpta (ofatumumab injection)
• Mayzent (siponimod tablets)
• Tysabri (natalizumab)
• Ocrevus (ocrelizumab injection)
• Zeposia (ozanimod capsules)
• Plegridy (peginterferon beta-1a injection for subcutaneous use)
• Prednisone (prednisone tablets, usp)